Quoin Pharmaceuticals Ltd. (QNRX) ROA
- 2026-06-30: ROA -155.94%.
- 2026-03-31: ROA -108.27%.
- 2025-12-31: ROA -77.51%.
- 2025-09-30: ROA -214.33%.
Complete source-backed roa history.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -155.94% |
| 2026-03-31 | -108.27% |
| 2025-12-31 | -77.51% |
| 2025-09-30 | -214.33% |
| 2025-06-30 | -136.54% |
| 2025-03-31 | -80.64% |
| 2024-12-31 | -57.05% |
| 2024-09-30 | -76.40% |
| 2024-06-30 | -58.90% |
| 2024-03-31 | -52.17% |
| 2023-12-31 | -71.38% |
| 2023-09-30 | -57.33% |
| 2023-06-30 | -58.29% |
| 2023-03-31 | -55.83% |
| 2022-12-31 | -64.89% |
| 2022-09-30 | -116.79% |
| 2022-06-30 | -406.65% |
| 2021-12-31 | -229.38% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -77.51% |
| 2024-12-31 | -57.05% |
| 2023-12-31 | -71.38% |
| 2022-12-31 | -64.89% |
| 2021-12-31 | -229.38% |
| 2020-12-31 | -152.08% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |